Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vayarin
- Development stage
- Unknown
- Lead developer
- Vaya Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Vayarin is a prescription medical food for the clinical dietary management of complex lipid imbalances associated with attention deficit hyperactivity disorder (ADHD) in children. It contains Lipirinen, a proprietary composition of phosphatidylserine conjugated to omega-3 fatty acids enriched with EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). Phosphatidylserine in the nervous system has been implicated in numerous membrane-associated functions, such as maintaining cell membrane integrity and cell-to-cell communication. It regulates important proteins in neuronal cell membranes, including sodium/calcium ATPase and protein kinase C, and influences neurotransmitter activity, such as the release of acetylcholine, dopamine, and noradrenaline.
- Brand names
- Vayarin
- Other names
- Phosphatidylserine-omega-3Phosphatidylserine-omega3Phosphatidylserine-omega 3Phosphatidylserine, DHA, and EPA
02
Targets
BRAF (B-Raf proto-oncogene, serine/threonine kinase)PKC (Protein kinase C family)
Beyond the preview
Go deeper on Vayarin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vayarin.